GlassScriptPhysician profile
Beth M Phillips
NPI 1326110263
$50,997.29
in general payments reported to CMS, 2019-2025
11 companies · $38K in 2025
The $38K reported for 2025 was more than what 99% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $425 · 2022: $819 · 2023: $1,660 · 2024: $10K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $39K · Travel and Lodging: $5,980 · Food and Beverage: $5,241 · Education: $16.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $38,515.00 |
| Travel and Lodging | $5,980.43 |
| Food and Beverage | $5,241.26 |
| Education | $16.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $49,338.69 | 2022-2025 | |
| Allergan, INC. | $1,033.44 | 2021-2022 | |
| Merz North America, INC. | $339.15 | 2023-2024 | |
| Musculoskeletal Transplant Foundation INC. | $95.29 | 2022-2024 | |
| Tela Bio, INC. | $39.05 | 2021-2022 | |
| Motiva USA, LLC | $33.33 | 2025 | |
| Mentor Worldwide LLC | $28.08 | 2023 | Artoura Breast Tissue Expander |
| Vertex Pharmaceuticals Incorporated | $27.86 | 2025 | |
| Integra Lifesciences Corporation | $24.57 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Galderma Laboratories, L.P. | $22.26 | 2021 | |
| Kerecis Limited | $15.57 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.